Awake Fiberoptic Intubation

2

Review clinical trials related to Awake Fiberoptic Intubation. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Comparison of Two Sedation Regimens for Awake Fiberoptic Intubation

The purpose of this study is to examine the effects of different sedation drugs used for the awake fiberoptic intubation procedure. Benzodiazapines and narcotics (such as midazolam and fentanyl) are standard drugs used for sedation during awake fiberoptic intubation. Dexmedetomidine, midazolam, and fentanyl are approved by the Food and Drug Administration (FDA) procedural sedation. These drugs might be given to the patient regardless of their participation in the study. In addition to midazolam and fentanyl study subjects will also receive either dexmedetomidine or a placebo (a salt solution that contains no drug). It is believed that dexmedetomidine will not slow down breathing as much as the combination of the valium-like drug and narcotic. In our study, we are trying to determine if this is the best drug for sedation during an awake fiberoptic procedure.

Participants needed: 96
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: University of Illinois at ChicagoUpdated: Nov 29, 2024Locations: 1
Eligibility criteria

Subjects with potentially difficult airways who require awake fiberoptic intubat...

Anyone who does not meet the inclusion criteria

Status: Recruiting

Sevoflurane Sedation as an Alternative for Awake Fiberoptic Intubation in Difficult Airway Patients

The aim of this study is to compare patient satisfaction and intubating conditions with fiber optic intubation under sevoflurane sedation versus airway blocks in difficult airway patients

Participants needed: 70
Trial details
Age: 18-50Biological sex: AllType: InterventionalSponsor: Tanta UniversityUpdated: Sep 19, 2024Locations: 1
Eligibility criteria

Age from 18 to 50 years. [+3]

Patient refusal. [+5]